The introduction of antiretroviral therapy in Malawi;De introductie van antiretrovirale therapie in Malawi

Nederlands Tijdschrift voor Geneeskunde

Volumn 150, Issue 50, 2006, Pages 2774-2778

  Zijlstra, E E ^a   Van Oosterhout, J J G ^a  

^a UNIVERSITY OF MALAWI   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

HEALTH CARE PERSONNEL; HEALTH EDUCATION; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALAWI; MORTALITY; OUTPATIENT; OUTPATIENT DEPARTMENT; PATIENT ASSESSMENT; PREVALENCE; REVIEW;

ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; HIV INFECTIONS; HUMANS; MALAWI; PREVALENCE; PROGRAM EVALUATION;

EID: 33846401738     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. National Statistical Office (NSO), ORC Macro. Malawi demographic and health survey 2004. Calverton: NSO; 2005.
2. Lewis DK, Callaghan M, Phiri K, Chipwete J, Kublin JG, Borgstein E, et al. Prevalence and indicators of HIV and AIDS among adults admitted to medical and surgical wards in Blantyre, Malawi. Trans R Soc Trop Med Hyg. 2003;97:91-6.
3. Oosterhout JJG van, Bodasing N, Kumwenda JJ, Nyirenda C, Mallewa J, Cleary PR, et al. Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi. Trop Med Int Health. 2005; 10:464-70.
4. Treatment of AIDS. A five-year plan for the provision of antiretroviral therapy and good management of HIV-related diseases to HIV-infected patients in Malawi 2006-2010. Lilongwe: Ministry of Health; 2005.
5. Harries AD, Libamba E, Schouten EJ, Mwansambo A, Salaniponi FM, Mpazanje R. Expanding antiretroviral therapy in Malawi: drawing on the country's experience with tuberculosis. BMJ. 2004;329:1163-6.
6. Harries AD, Schouten EJ, Libamba E. Scaling up antiretroviral treatment in resource-poor settings. Lancet. 2006;367:1870-2.
7. Ferradini L, Jeannin AJ, Pinoges L, Izopet J, Odhiambo D, Mankhambo L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet. 2006;367: 1335-42.
8. Harries AD, Hargreaves NJ, Gausi F, Kwanjana JH, Salaniponi FM. High early death rate in tuberculosis patients in Malawi. Int J Tuberc Lung Dis. 2001;5:1000-5.
9. Anglaret X, Chêne G, Attia A, Toure S, Lafont S, Combe P, et al. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d'Ivoire: a randomised trial. Cotrimo-CI Study Group. Lancet. 1999;353:1463-8.
10. 4-cell count, and viral load in HIV infection in rural Uganda. Lancet. 2004;364:1428-34.
11. Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis. 2002;34:1115-21.
12. Laurent C, Kouanfack C, Koulla-Shiro S, Nkoue N, Bourgeois A, Calmy A, et al. Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial. Lancet. 2004;364: 29-34.
13. Makombe S, Libamba E, Mhango E, de Ascurra Teck O, Aberle-Grasse J, Hochgesang M, et al. Who is accessing antiretroviral therapy during national scale-up in Malawi? Trans R Soc Trop Med Hyg. 2006;100: 975-9.
14. Kwanjana J, Harries AD, Gausi F, Nyangulu DS, Salaniponi FM. HIV-seroprevalence in patients with tuberculosis in Malawi. Malawi Medical Journal. 2001;13:7-10.